This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
: Organ support-free days - XML Representation
Raw xml | Download
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="7753"/>
<meta>
<versionId value="6"/>
<lastUpdated value="2023-12-01T16:35:08.324Z"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: EvidenceVariable</b><a name="7753"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource EvidenceVariable "7753" Version "6" Updated "2023-12-01 16:35:08+0000" </p></div><p><b>EvidenceVariableDefinition</b>: Days alive and free of organ support to day 21: The ordinal scale includes a score of –1 (in-hospital death at any time through 90 days, the worst possible outcome), a score of 0 to 21 (the numbers of days alive without organ support), and a score of 22 (survival until hospital discharge without receipt of organ support, the best possible outcome). <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></p><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/EvidenceVariable/7753</code></p><p><b>identifier</b>: FEvIR Object Identifier: 7753</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: Organ_support_free_days</p><p><b>title</b>: Organ support-free days</p><p><b>status</b>: active</p><p><b>date</b>: 2022-03-07 00:50:50+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: The primary outcome was organ support–free days, evaluated on an ordinal scale that combined in-hospital death and the number of days free of cardiovascular or respiratory organ support up to day 21 among patients who survived to hospital discharge. Patients who were discharged from the hospital before day 21 were assumed to be alive and free of organ support through day 21. Any death during the index hospitalization through 90 days was assigned the worst score on the outcome scale (–1). This end point reflects both the use of ICU-level interventions and survival, with higher values indicating better outcomes.</p><p><b>note</b>: Organ support was defined as oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes., The methods for one of the included trials stated 'Organ Support is defined as receipt of invasive or non-invasive mechanical ventilation, high flow nasal oxygen, vasopressor therapy, or ECMO support'</p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style="display: none">*</td><td>cite-as</td><td>Organ support-free days [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 7753. Revised 2022-03-07. Available at: https://fevir.net/resources/EvidenceVariable/7753. Computable resource at: https://fevir.net/resources/EvidenceVariable/7753.</td></tr></table><p><b>handling</b>: ordinal</p></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-definition">
<valueCodeableReference>
<concept>
<text
value="Days alive and free of organ support to day 21: The ordinal scale includes a score of –1 (in-hospital death at any time through 90 days, the worst possible outcome), a score of 0 to 21 (the numbers of days alive without organ support), and a score of 22 (survival until hospital discharge without receipt of organ support, the best possible outcome)."/>
</concept>
</valueCodeableReference>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="https://fevir.net/resources/EvidenceVariable/7753"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="7753"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<version value="1.0.0-ballot"/>
<name value="Organ_support_free_days"/>
<title value="Organ support-free days"/>
<status value="active"/>
<date value="2022-03-07T00:50:50.578Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="The primary outcome was organ support–free days, evaluated on an ordinal scale that combined in-hospital death and the number of days free of cardiovascular or respiratory organ support up to day 21 among patients who survived to hospital discharge. Patients who were discharged from the hospital before day 21 were assumed to be alive and free of organ support through day 21. Any death during the index hospitalization through 90 days was assigned the worst score on the outcome scale (–1). This end point reflects both the use of ICU-level interventions and survival, with higher values indicating better outcomes."/>
<note>
<text
value="Organ support was defined as oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes."/>
</note>
<note>
<text
value="The methods for one of the included trials stated 'Organ Support is defined as receipt of invasive or non-invasive mechanical ventilation, high flow nasal oxygen, vasopressor therapy, or ECMO support'"/>
</note>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<relatedArtifact>
<type value="cite-as"/>
<citation
value="Organ support-free days [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 7753. Revised 2022-03-07. Available at: https://fevir.net/resources/EvidenceVariable/7753. Computable resource at: https://fevir.net/resources/EvidenceVariable/7753."/>
</relatedArtifact>
<handling value="ordinal"/>
</EvidenceVariable>
|
Propose a change